Claus Jensen, Enterprise Architect at Novozymes

In this podcast we speak to Claus Jensen, Enterprise Architect at
Novozymes. Novozymes is a global biotechnology company
headquartered in Denmark and focuses on the research,
development, and production of industrial enzymes,
microorganisms, and biopharmaceutical ingredients. We begin
talking about how the COVID 19 pandemic has effected Novozymes
and what the EA team we asked to do … then Claus goes into more
detail about his vision for the “new normal” when for employees
and consumers.